Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer.
Coudert
B
B
Medical Oncology, Centre GF Leclerc, Dijon, France. bcoudert@dijon.fnclcc.fr <bcoudert@dijon.fnclcc.fr>